Purchase Order 75N98026P01433

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $90.1K firm fixed-price purchase order to Oxford Nanopore Technologies Inc. for a PromethION 2 integrated sequencing unit and related support services. This severable purchase order (ONT-077966) was awarded on July 18, 2025, with an ultimate completion date of July 17, 2026, and will be performed in New York, NY. The award includes no set-aside designation and represents a direct procurement of advanced genomic sequencing...

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Oxford Nanopore Technologies Inc. for $83,900.00 on July 10, 2026, for PromethION flow cell packs (DNA and RNA volumes) on a firm fixed price basis.</p> <p>Performance occurs in New York, New York. The order is not set-aside. Ultimate completion is scheduled for July 9, 2027.</p>

The National Institute on Alcohol Abuse and Alcoholism (NIAAA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $17,380 purchase order to Oxford Nanopore Technologies Inc. for CAS9 sequencing kits. The firm fixed price order is for delivery of the requested products between July 24 and August 4, 2023. Oxford Nanopore Technologies Inc. will perform as the prime contractor, with all work taking place in New York, NY....

The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order valued at thirty-two thousand two hundred eighty dollars to Oxford Nanopore Technologies Inc. for DNA sequencing kits and PromethION flow cell packs. The solicitation requested quotes for six ultra-long DNA sequencing kits and one pack of eight PromethION flow cells to support long read DNA and RNA sequencing on the awardee's...

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order to Oxford Nanopore Technologies Inc. for $22,500 on January 16, 2026, for PromethION advanced training. Performance occurs in New York, New York, with an ultimate completion date of January 15, 2027. No set-aside applies to this order.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism awarded a purchase order to Life Technologies Corporation for $109,676.46 on August 7, 2026, for whole-exome sequencing enrichment and regents to identify rare sequence variants across protein-coding sequences in newly recruited patients with alcohol-related phenotypes. Work is performed in Carlsbad, California. The order is firm fixed price with an ultimate completion date of August 6, 2027.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism issued a delivery order to Illumina, Inc. on August 28, 2017, with a ceiling value of $9,819.42 for sequencing consumables and services under a firm fixed-price arrangement.</p> <p>Place of performance is Bethesda, MD. The order was completed by September 2, 2020. No set-aside was used. The source does not identify the parent vehicle for this delivery order.</p>

<p>The National Institute on Alcohol Abuse and Alcoholism issued a $25,459.20 delivery order to Illumina, Inc. on August 7, 2019, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, Maryland. The order has a firm fixed price and an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Institute on Aging awarded a purchase order to Oxford Nanopore Technologies Inc. for $150,000 on October 28, 2024, for a license and warranty covering a PromethION 48 sequencing instrument (serial number P48_051). Performance occurs at Bethesda, Maryland, with an ultimate completion date of October 27, 2025. The order is firm fixed price with no set-aside designation.</p>

<p>The National Institute on Aging awarded a purchase order to Oxford Nanopore Technologies Inc. on July 21, 2026 for long sequencing kits, valued at $228,645.00 and firm-fixed-priced, with an ultimate completion date of July 20, 2027. Place of performance is Baltimore, Maryland. The order procures long-read sequencing consumables and reagents compatible with Oxford Nanopore sequencing platforms, supporting genomic research initiatives.</p>